Coreg Information
What's inside Coreg
Coreg Active Ingredients: carvedilol, details.| Coreg Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Coreg 6.25 mg | tablet | oral | 1.0 each | OTC |
| Coreg 12.5 mg | tablet | oral | 1.0 each | OTC |
| Coreg 25 mg | tablet | oral | 1.0 each | OTC |
| Coreg 3.125 mg | tablet | oral | 1.0 each | OTC |
Recent Coreg Side Effects
Posted by jc3747 2 months ago
My husband was put on Coreg in the hospital and he is on oxygen 24/7, after 5 days of Coreg his oxygen level dropped to 60 af...
Posted by briman 10 months ago
anxiety
depression
light headedness
I stopped taking this med after one month
this was 3 yrs ago
and I'm still...
Posted by docsoho about 1 year ago
Started coreg in 2000. 2-3 Months into taking Coreg I noticed my back beginning to ache. I questioned my Dr. about possible ...
Coreg in the News
PhRMA Celebrates 20th Anniversary of Discoverers Award - Therapeutics Daily (subscription) (press release)
GlaxoSmithKline's (GSK) cardiovascular medicine Coreg has reduced the mortality of congestive heart failure and changed the paradigm for ...
Thu Feb 14 19:01:59 -0500 2008
Court Denies Dr. Reddy’s Request to Invalidate Teva’s Patent - FDA news (subscription)
... Coreg — a judge has denied Dr. Reddy’s Laboratories’ motion for partial summary judgment that two claims in one of the contested patents are invalid. ...
Fri Mar 07 18:39:23 -0500 2008
Flamel Technologies Announces Projected Release Date of Fourth - Ad-Hoc-News (Pressemitteilung)
... for the oral administration of small molecule drugs; it is the intellectual platform licensed by GlaxoSmithKline for the development of COREG CR'. ...
Mon Feb 25 22:39:05 -0500 2008
Coreg Chemical Information
carvedilol - A synthetic antihypertensive methoxyphenoxy- 2-propanol derivative with no intrinsic sympathomimetic activity, Carvedilol acts as a nonselective beta-adrenoceptor blocking agent (S(-) enantiomer) and as an alpha 1-adrenoceptor blocker (R(+) and S(-) enantiomers). Its acts more strongly on beta-receptors than on alpha 1-receptors, reduces peripheral vascular resistance by vasodilation, and prevents reflex tachycardia (beta-blockade) so that heart rate is either unchanged or decreased. Carvedilol also reduces renin release through beta-blockade. (NCI04)
Coreg RSS Feed